Never Surrender: Pain Therapeutics Eyes 2016 Remoxy Filing
This article was originally published in The Pink Sheet Daily
Executive Summary
Pain Therapeutics said it will file the opioid with FDA in the first quarter of 2016, based on clinical trial data conducted by its former partner Pfizer.